Prelude Capital Management, LLC Alkermes Plc. Transaction History

Prelude Capital Management, LLC

  • $1.39 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$23.37 - $32.13 $255,060 - $350,666
-10,914 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$18.78 - $25.15 $204,964 - $274,487
10,914 New
10,914 $268,000
Q1 2020

May 15, 2020
SELL
$13.06 - $21.24 $115,045 - $187,103
-8,809 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$17.29 - $21.74 $152,307 - $191,507
8,809 New
8,809 $180,000

Others Institutions Holding ALKS

# of Institutions
347
Shares Held
183M
Call Options Held
209K
Put Options Held
89.4K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.66B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email